Susquehanna International Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-32,000
Closed -$606K 13994
2025
Q4
$606K Sell
32,000
-10,800
-25% -$200K ﹤0.01% 8352
2025
Q3
$798K Buy
42,800
+4,000
+10% +$74.7K ﹤0.01% 7873
2025
Q2
$715K Sell
38,800
-32,200
-45% -$571K ﹤0.01% 8306
2025
Q1
$1.24M Buy
71,000
+23,200
+49% +$391K ﹤0.01% 6713
2024
Q4
$828K Sell
47,800
-33,700
-41% -$615K ﹤0.01% 7434
2024
Q3
$1.56M Sell
81,500
-78,200
-49% -$1.32M ﹤0.01% 5806
2024
Q2
$2.46M Buy
159,700
+36,200
+29% +$517K ﹤0.01% 4685
2024
Q1
$1.82M Sell
123,500
-12,600
-9% -$174K ﹤0.01% 5549
2023
Q4
$1.94M Buy
136,100
+28,500
+26% +$405K ﹤0.01% 5420
2023
Q3
$1.5M Buy
107,600
+76,200
+243% +$975K ﹤0.01% 5742
2023
Q2
$370K Sell
31,400
-59,200
-65% -$674K ﹤0.01% 9014
2023
Q1
$1.04M Sell
90,600
-7,900
-8% -$97.7K ﹤0.01% 6713
2022
Q4
$1.23M Sell
98,500
-58,600
-37% -$747K ﹤0.01% 5740
2022
Q3
$2.06M Sell
157,100
-110,100
-41% -$1.63M ﹤0.01% 4874
2022
Q2
$3.73M Buy
267,200
+128,100
+92% +$1.71M ﹤0.01% 3696
2022
Q1
$2.07M Buy
139,100
+74,800
+116% +$1.02M ﹤0.01% 5393
2021
Q4
$871K Sell
64,300
-70,500
-52% -$998K ﹤0.01% 7650
2021
Q3
$2.09M Sell
134,800
-28,400
-17% -$480K ﹤0.01% 5732
2021
Q2
$3.04M Buy
163,200
+11,800
+8% +$210K ﹤0.01% 4989
2021
Q1
$2.69M Buy
151,400
+11,200
+8% +$197K ﹤0.01% 5213
2020
Q4
$2.49M Buy
140,200
+14,300
+11% +$228K ﹤0.01% 4644
2020
Q3
$1.75M Buy
125,900
+36,500
+41% +$536K ﹤0.01% 4880
2020
Q2
$1.29M Buy
89,400
+23,900
+36% +$314K ﹤0.01% 5347
2020
Q1
$715K Buy
65,500
+13,400
+26% +$247K ﹤0.01% 6140
2019
Q4
$1.11M Sell
52,100
-56,800
-52% -$1.27M ﹤0.01% 5320
2019
Q3
$2.5M Buy
108,900
+66,900
+159% +$1.43M ﹤0.01% 3786
2019
Q2
$827K Sell
42,000
-63,400
-60% -$1.24M ﹤0.01% 6127
2019
Q1
$2.38M Sell
105,400
-54,200
-34% -$1.03M ﹤0.01% 3490
2018
Q4
$3.6M Buy
159,600
+59,000
+59% +$1.19M ﹤0.01% 2684
2018
Q3
$2.34M Buy
100,600
+40,400
+67% +$915K ﹤0.01% 3744
2018
Q2
$1.32M Buy
60,200
+22,100
+58% +$432K ﹤0.01% 4787
2018
Q1
$672K Sell
38,100
-53,400
-58% -$941K ﹤0.01% 6047
2017
Q4
$1.72M Buy
91,500
+16,500
+22% +$328K ﹤0.01% 4181
2017
Q3
$1.65M Buy
75,000
+21,400
+40% +$483K ﹤0.01% 4275
2017
Q2
$1.29M Buy
53,600
+32,100
+149% +$816K ﹤0.01% 4732
2017
Q1
$600K Sell
21,500
-13,300
-38% -$349K ﹤0.01% 6160
2016
Q4
$850K Buy
34,800
+14,300
+70% +$328K ﹤0.01% 5870
2016
Q3
$516K Sell
20,500
-6,600
-24% -$158K ﹤0.01% 6002
2016
Q2
$559K Buy
+27,100
New +$565K ﹤0.01% 5935
2015
Q3
Sell
-7,800
Closed -$201K 10106
2015
Q2
$201K Buy
+7,800
New +$221K ﹤0.01% 9282
2014
Q4
Sell
-9,300
Closed -$226K 10025
2014
Q3
$226K Buy
+9,300
New +$258K ﹤0.01% 8473

Other funds holding SBRA

Susquehanna International Group's SBRA Position: Q1 2026 in Review

Susquehanna International Group increased its Sabra Healthcare REIT (SBRA) stake by 1,107% in Q1 2026, buying an estimated $2.93M and bringing the position to 162,436 shares worth $3.12M. The position accounts for ﹤0.01% of the portfolio, ranked #5194.

Susquehanna International Group first reported a position in SBRA in Q4 2013 and has held it in 41 quarters since. The position peaked at $5.3M in Q2 2025. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • Susquehanna International Group held 162,436 shares of Sabra Healthcare REIT worth $3.12M as of Q1 2026.
  • Susquehanna International Group bought 148,977 Sabra Healthcare REIT shares in Q1 2026, an estimated $2.93M.
  • Sabra Healthcare REIT made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5194 holding.
  • Susquehanna International Group first reported a position in Sabra Healthcare REIT in Q4 2013 and has held it in 41 quarters since.
  • Susquehanna International Group's Sabra Healthcare REIT position peaked at $5.3M in Q2 2025.
  • 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.